Shares in pharmaceutical giant GSK (LON:GSK) gained on positive trial results for two of its new cancer drugs. The company presented the results at the 2026 World Conference on Lung Cancer in Seoul, South Korea. Positive results for two drugs In the first trial, the firm’s Jideytro treatment delivered positive results in patients with non-small … Continue reading GSK gains on positive trial results for new cancer drugs